IRIS
DE ROSA, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.791
NA - Nord America 2.290
AS - Asia 1.366
SA - Sud America 232
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 6.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.226
RU - Federazione Russa 1.208
SG - Singapore 686
IT - Italia 640
HK - Hong Kong 273
DE - Germania 250
CN - Cina 244
BR - Brasile 218
FI - Finlandia 176
NL - Olanda 155
IE - Irlanda 83
FR - Francia 59
UA - Ucraina 58
GB - Regno Unito 53
CA - Canada 49
IN - India 44
CI - Costa d'Avorio 40
SE - Svezia 32
ZA - Sudafrica 23
VN - Vietnam 21
BD - Bangladesh 14
BG - Bulgaria 14
MX - Messico 13
KR - Corea 11
TR - Turchia 11
AT - Austria 9
MK - Macedonia 9
BE - Belgio 8
PL - Polonia 8
PH - Filippine 7
IQ - Iraq 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
IR - Iran 5
PY - Paraguay 5
UZ - Uzbekistan 5
AR - Argentina 4
CH - Svizzera 4
ES - Italia 4
NP - Nepal 4
PK - Pakistan 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
RS - Serbia 3
EC - Ecuador 2
EG - Egitto 2
MT - Malta 2
NO - Norvegia 2
TH - Thailandia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
JP - Giappone 1
KW - Kuwait 1
LB - Libano 1
NI - Nicaragua 1
NR - Nauru 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SD - Sudan 1
SI - Slovenia 1
UY - Uruguay 1
Totale 6.753
Salva come PNG Salva come JPEG
Città #
Chandler 461
Singapore 431
Moscow 279
Hong Kong 273
Ashburn 158
Munich 158
Santa Clara 146
Amsterdam 141
Naples 96
Millbury 91
Helsinki 84
Napoli 78
Princeton 65
Nanjing 63
Beijing 62
Columbus 56
Des Moines 56
Boston 42
Seattle 33
Ottawa 31
Lawrence 28
Turku 27
Wilmington 25
Norwalk 24
Hefei 21
Dallas 20
Rome 19
Jacksonville 17
Dong Ket 16
Pune 16
Los Angeles 14
Hebei 13
Lauterbourg 13
Shenyang 13
Sofia 13
Nuremberg 12
Redwood City 12
Dearborn 11
Falkenstein 11
Frankfurt am Main 11
London 11
Nanchang 11
Jiaxing 10
São Paulo 10
Washington 10
Milan 9
Bari 8
Belo Horizonte 8
Gricignano di Aversa 8
Nola 8
Brooklyn 7
Houston 7
New York 7
Sassari 7
Seoul 7
Toronto 7
Brussels 6
Chicago 6
Dublin 6
Düsseldorf 6
Fairfield 6
Goiânia 6
San Mateo 6
The Dalles 6
Torre Annunziata 6
Afragola 5
Ann Arbor 5
Augusta 5
Bauru 5
Brasília 5
Caserta 5
Changsha 5
Dhaka 5
Johannesburg 5
Jyväskylä 5
Kronberg 5
Monteforte Irpino 5
Sant'arpino 5
Shanghai 5
Tashkent 5
Torino 5
Woodbridge 5
Bexley 4
Boardman 4
Campagna 4
Indiana 4
Izmir 4
Kochi 4
Mexico City 4
New Delhi 4
Portsmouth 4
Pozzuoli 4
Roubaix 4
Salerno 4
San Francisco 4
San Giuseppe Vesuviano 4
Serra 4
Simi Valley 4
Warsaw 4
Amman 3
Totale 3.485
Salva come PNG Salva come JPEG
Nome #
A case of restless leg syndrome in a family with LRRK2 gene mutation. 209
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 150
Alteration of endosomal trafficking is associated with neurodegenerative diseases 127
GBA-Related Parkinson’s Disease:Dissection of Genotype–Phenotype Correlates in a LargeItalian Cohort 109
Parkinsonism in adult-onset Rasmussens's encephalitis: a clinical picture presenting as corticobasal syndrome 95
Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis 95
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 89
Pathological laughter as onset symptom in atypical parkinsonisms 89
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 88
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 88
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 86
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 86
Chorea-acanthocytosis without chorea: Expanding the clinical phenotype 86
Reproductive function of long-term treated patients with hepatic onset of Wilson's disease: a prospective study 86
Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report 85
Prevalence and features of non-motor symptoms in Wilson's disease 85
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 83
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection 83
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 81
PERK-mediated unfolded protein response activation and oxidative stress in PARK20 fibroblasts 81
Screening for Fabry disease in a series of Parkinson’s disease patients and literature review 80
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 80
Non-motor symptoms and cardiac innervation in SYNJ1-related parkinsonism 79
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 78
Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a 77
Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington's disease 77
Cutaneous sensory and autonomic denervation in Progressive Supranuclear Palsy 77
Frontal defect contribution to decreasing of body mass index in Parkinson's disease patients 76
Peripheral markers of autophagy in polyglutamine diseases 76
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 76
Animal-Assisted Therapy in Elderly Patients: Evidence and Controversies in Dementia and Psychiatric Disorders and Future Perspectives in Other Neurological Diseases 76
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 75
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 74
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 74
Myocardial (123)I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 73
The flavor test is a sensitive tool in identifying the flavor sensorineural dysfunction in Parkinson's disease 71
Mobitz type I and II atrioventricular blocks during fingolimod therapy 70
Cognitive profile and 18F-fluorodeoxyglucose PET study in LRRK2-related Parkinson's disease 69
Antiphospholipid-related chorea. 69
The Italian tremor Network (TITAN): rationale, design and preliminary findings. 69
Screening for dopa-responsive dystonia in patients with scans without evidence of dopaminergic deficiency (SWEDD). 68
Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study 68
Efficacy of dopamine agonist treatment in delayed-onset parkinsonism due to midbrain hemorrhage. 66
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 66
Motor and non-motor features in Parkinson's Disease patients carrying GBA gene mutations 65
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 65
Co-existence of primary hyperparathyroidism and Parkinson's disease in three patients: an incidental finding? 64
Postganglionic sudomotor denervation in patients with multiple system atrophy 63
The magnetic apraxia of Denny-Brown 62
Conventional MRI findings in hereditary degenerative ataxias: a pictorial review 62
Validation of the Italian version of the PSP Quality of Life questionnaire 61
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 60
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL. 59
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL. 59
Suppression of myoclonus in SCA2 by piracetam. 59
A longitudinal real-life comparison study of natalizumab and fingolimod 59
The importance of being persistent to multiple sclerosis treatments 59
Othello syndrome in Parkinson's disease: a systematic review and report of a case series 59
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 58
Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis 58
A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia. 58
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 58
Constructional Apraxia is related to Different Cognitive Defect's across Dementia 58
Screening for RFC-1 pathological expansion in late-onset ataxias: a contribution to the differential diagnosis. 58
The Framingham cardiovascular risk score in multiple sclerosis 56
Parkinsonism may be part of the symptom complex of DOOR syndrome. 56
MRI analysis of two cases of cerebrotendinous xanthomathosis (Studio RM di due casi di xantomatosi cerebro-tendinea) 55
Dissociative Identity Disorder: Restoration of Executive Functions After Switch from Alter to Host Personality. 55
Anti-CRMP5 paraneoplastic chorea: selective external capsule MRI involvement resolving after tumour resection 55
Assessment of non-motor and autonomic symptoms in Wilson's disease patients 55
Does motor cortex plasticity depend on the type of mutation in the leucine-rich repeat kinase 2 gene? 53
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 53
The Heterogeneity of Early Parkinson's Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 53
The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy. 52
Genetic Screening for the LRRK2 R1441C and G2019S Mutations in Parkinsonian Patients from Campania. 52
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants 51
Subacute combined degeneration of the spinal cord in a vegan. 51
Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing 51
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 51
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 50
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 50
Screening for Niemann-Pick type C disease in neurodegenerative diseases 50
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 49
Correction to: Peripheral markers of autophagy in polyglutamine diseases (Neurological Sciences, (2018), 39, 1, (149-152), 10.1007/s10072-017-3156-6) 48
Introversion and Neuroticism in Akinetic-Rigid Parkinson’s Disease: Association With Frontal-Executive Dysfunction 47
Neurophysiological evaluation of motor corticospinal pathways by TMS in idiopathic early-onset Parkinson's disease. 45
insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early,drug-naive Parkinson's disease. 44
Cardiovascular profile improvement during Natalizumab treatment 44
Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population. 44
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 41
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 41
Using global team science to identify genetic parkinson's disease worldwide 41
Gender differences in microRNA expression in levodopa-naive PD patients 41
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project 39
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. 39
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 38
Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations. 36
Constructional Impairments and Their Neural Correlates in Nondemented Adults With Cerebral Autosomal-dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy 35
Prevalence and features of headache in Parkinson's disease: the role of dopamine 34
Totale 6.677
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.432
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.432
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 15 8 20 16 29 27 21 25 17 4 37 23
2021/2022627 16 11 4 11 22 17 13 19 94 53 133 234
2022/20231.037 115 108 34 88 117 119 18 69 163 152 47 7
2023/2024637 32 92 72 54 52 66 34 90 9 12 82 42
2024/20253.528 149 104 24 45 132 175 520 239 251 317 1.281 291
2025/2026102 102 0 0 0 0 0 0 0 0 0 0 0
Totale 7.049